MRP ₹186
(Inclusive of all Taxes)
₹27.9 Cashback (15%)
%2520JP_OneCard.png?tr=q-85,f-webp,w-50,dpr-1,c-at_max){kind=small}
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
निर्माता/विपणक :
स्काईसन लाइफ साइंसेज प्राइवेट लिमिटेड
सेवन का प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
इसके बाद या इसके बाद समाप्त होता है :
Jan-27
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Telmijub AM-H 40 Tablet:
Co-administration of Aliskiren with Telmijub AM-H 40 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Telmijub AM-H 40 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking Cisapride and Telmijub AM-H 40 Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Cisapride and Telmijub AM-H 40 Tablet together is generally avoided as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, or fast or pounding heartbeats, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
Taking Cisapride and Telmijub AM-H 40 Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Cisapride and Telmijub AM-H 40 Tablet together is generally avoided as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, or fast or pounding heartbeats, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
HydrochlorothiazideDofetilide
Critical
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking Dofetilide and Telmijub AM-H 40 Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Dofetilide and Telmijub AM-H 40 Tablet together is not recommended as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Dofetilide and Telmijub AM-H 40 Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Dofetilide and Telmijub AM-H 40 Tablet together is not recommended as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
AmlodipineDantrolene
Critical
How does the drug interact with Telmijub AM-H 40 Tablet:
Using Telmijub AM-H 40 Tablet together with dantrolene may increase the risk of hyperkalemia (high blood potassium).
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with Dantrolene can cause an interaction, consult a doctor before taking it. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Using Telmijub AM-H 40 Tablet together with dantrolene may increase the risk of hyperkalemia (high blood potassium).
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with Dantrolene can cause an interaction, consult a doctor before taking it. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking Potassium citrate with Telmijub AM-H 40 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Telmijub AM-H 40 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Telmijub AM-H 40 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Telmijub AM-H 40 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking quinapril with Telmijub AM-H 40 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Telmijub AM-H 40 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Co-administration of amiloride with Telmijub AM-H 40 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Co-administration of amiloride with Telmijub AM-H 40 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking spironolactone with Telmijub AM-H 40 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking spironolactone with Telmijub AM-H 40 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Co-administration of Telmijub AM-H 40 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Telmijub AM-H 40 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking Telmijub AM-H 40 Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Taking Telmijub AM-H 40 Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Drug-Food Interactions
AMLODIPINE-5MG+HYDROCHLOROTHIAZIDE-12.50MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
AMLODIPINE-5MG+HYDROCHLOROTHIAZIDE-12.50MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with potassium-containing salt substitutes or potassium supplements can cause high levels of potassium in blood. Avoid taking potassium-containing salt substitutes or potassium supplements while being treated with Telmijub AM-H 40 Tablet.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with potassium-containing salt substitutes or potassium supplements can cause high levels of potassium in blood. Avoid taking potassium-containing salt substitutes or potassium supplements while being treated with Telmijub AM-H 40 Tablet.
शराब
असुरक्षित
अप्रिय दुष्प्रभावों से बचने के लिए आपको टेल्मिजूब एएम-एच 40 टैबलेट 10 के साथ शराब का सेवन न करने की सलाह दी जाती है।
गर्भावस्था
सावधानी
जब तक आपका डॉक्टर इसे आवश्यक न समझे, गर्भावस्था के दौरान टेल्मिजूब एएम-एच 40 टैबलेट 10 की अनुशंसा नहीं की जाती है। आपका डॉक्टर आपको इसे देने से पहले लाभों और किसी भी संभावित जोखिम का आकलन करेगा।
स्तनपान
सावधानी
स्तनपान के दौरान टेल्मिजूब एएम-एच 40 टैबलेट 10 की अनुशंसा नहीं की जाती है। हालाँकि, आपका डॉक्टर स्तनपान के दौरान आपको यह दवा लिख सकता है यदि उसे लगता है कि आपको होने वाला लाभ जोखिम से अधिक है। आपको डॉक्टर की सलाह के बिना टेल्मिजूब एएम-एच 40 टैबलेट 10 नहीं लेनी चाहिए।
ड्राइविंग
असुरक्षित
टेल्मिजूब एएम-एच 40 टैबलेट 10 लेने के बाद सावधानी से गाड़ी चलाने की सलाह दी जाती है क्योंकि यह आमतौर पर उनींदापन का कारण बनता है और ड्राइविंग क्षमता को प्रभावित करता है।
जिगर
सावधानी
टेल्मिजूब एएम-एच 40 टैबलेट 10 को सावधानी के साथ लेने की सलाह दी जाती है, खासकर यदि आपको लीवर की बीमारी है या इसका इतिहास रहा है। आपके डॉक्टर को आपकी चिकित्सा स्थिति और उपचार के प्रति आपकी प्रतिक्रिया के आधार पर खुराक बदलनी होगी।
गुर्दा
असुरक्षित
पुरानी किडनी की बीमारी (गंभीर गुर्दे की हानि) वाले रोगियों में इसकी अनुशंसा नहीं की जाती है। गंभीर गुर्दे की हानि वाले रोगियों में सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
बच्चे
सावधानी
टेल्मिजूब एएम-एच 40 टैबलेट 10 के लिए पर्याप्त वैज्ञानिक डेटा उपलब्ध नहीं है, इसलिए बाल रोग विशेषज्ञ से परामर्श करना सबसे अच्छा है।
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
